ABS Initiatives to Enhance Training the Next Generation of Brachytherapists
Daniel G. Petereit, MD, FASTRO, reviews brachytherapy and ABS initiatives to train physicians capable in administering the treatment.
Read More
Daniel G. Petereit, MD, FASTRO
Monument Health Cancer Care Institute
Rapid City, SD
Dr. Petereit received his BA from Augustana University in South Dakota and his MD from the University of South Dakota Medical School. He then completed his residency in radiation oncology at the University of Wisconsin-Madison. Dr. Petereit is a professor at the Sanford School of Medicine at the University of South Dakota and an adjunct associate professor at the University of Wisconsin School of Medicine and Public Health.
Dr. Petereit treats all types of cancer and specializes in brachytherapy. He is also a board examiner for the American Board of Radiology in gynecologic oncology. He has worked with the International Atomic Energy Agency (IAEA) to develop treatment guidelines for cervical cancer and the use of brachytherapy for other malignancies.
Dr. Petereit is a principal investigator on a number of grants funded by the National Cancer Institute and his clinical research has focused on gynecologic cancer, prostate cancer, brachytherapy, cancer disparities, and intensity modulated radiotherapy. Additionally, he has over 80 publications in peer-reviewed cancer journals and is an editor for Frontiers in Oncology. His professional goals include providing state-of-the art cancer care for patients throughout the region. To that end, Dr. Petereit developed the NCI-funded Walking Forward (WF) Program in 2002 to address high cancer incidence and mortality rates among American Indians in Western South Dakota.
Talks by Daniel G. Petereit, MD, FASTRO